The market for Contract Research Organizations is thriving due to the rapidly growing biologics market, increasing demand for clinical trials of medical devices, rising demand for outsourcing services in emerging countries, and also the expanding scope of CRO solutions with the adoption of technology. Also, there has been an increased demand for preclinical data generation with the rapid changes in the national and international regulators in the cosmetics and chemicals segments.
Furthermore, the increasing volume of new drugs entering the preclinical phase is also expected to boost the market’s growth. However, preclinical business is not yet fully tapped in India. Hence, there is a rising need for a competent player with the needed expertise to offer robust preclinical services that meet every expectation of a client.
Understanding the need to fill the gap, Bioneeds is one of the trusted and leading preclinical CRO that has been successfully providing integrated discovery, development and regulatory services to its niche clients across industries including pharmaceutical, biopharmaceutical, agrochemical, industrial chemical, herbal, nutraceutical and medical device companies. The company has also been working on many COVID-19 drugs and vaccines to screen from toxicity and immunogenicity.
“We are also covering niche areas in drug
testing, such as DMPK, canine toxicology, pharmacology, bioanalytical, alternative to animal studies and invitro bioassay among others. This gives us an edge over our competitors, hence, making us one of the preferred CROs in the market today. We are constantly upgrading ourselves and adopting the latest technology to set a benchmark in the market and cater to diverse needs of our various clients,” says Dr. S. N. Vinaya Babu, Founder & Managing Director at Bioneeds.
Future-ready Manufacturing Capabilities
Bioneeds has a state-of-the-art facility with 200,000 sq ft built-up area in a five acre campus in the serene outskirts of Bangalore. Bioneeds’ Synthetic Chemistry and Biopharma laboratories are housed in its Peenya facility spanning about 50,000 sq.ft. area. Their facilities are GLP certified and accredited by the AAALAC International (the Association for Assessment and Accreditation of Laboratory Animal Care International).
With cutting edge Drug Discovery and Development Labs, Bioneeds have been providing unparalleled support and services to its clients today; medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development services. It is an ISO 17025 company and has a recognized R&D unit by the Department of Scientific and Industrial Research (DSIR). All this is backed by its technologically adept team that has always been on the forefront in bringing the needed innovation in the market.
Always at the forefront of technology and teams to deliver the innovations Needed for the market
The Leader Behind the Company’s Success
Dr. S. N. Vinaya Babu has always been the brain behind the company’s growth strategies, wherein, he has successfully attracted the right talent to build the organization. He has been instrumental in terms of both strategic leadership and operational management in underpinning Bioneeds’ growth and evolution over the past several years. He completed his veterinary graduation in the year
1998 and has over 17 years of experience in various segments of preclinical development.
Adding to it, he has also published several research papers in national and international journals. During his long illustrious career, he has been bestowed with several awards and recognition such as, Global Indian Brands and Leaders 2019 by Forbes India, one of the 50 most promising entrepreneurs in Silicon India magazine, Recipient of the Raising Leadership Award 2017, Recipient of the Pharma Ratan Awards 2017.
